135 related articles for article (PubMed ID: 32344318)
1. The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score.
Dolan RD; McMillan DC
Crit Rev Oncol Hematol; 2020 Jun; 150():102962. PubMed ID: 32344318
[TBL] [Abstract][Full Text] [Related]
2. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.
McMillan DC
Proc Nutr Soc; 2008 Aug; 67(3):257-62. PubMed ID: 18452641
[TBL] [Abstract][Full Text] [Related]
3. A Survey of Attitudes towards the Clinical Application of Systemic Inflammation Based Prognostic Scores in Cancer.
Watt DG; Roxburgh CS; White M; Chan JZ; Horgan PG; McMillan DC
Mediators Inflamm; 2015; 2015():842070. PubMed ID: 26504363
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation, nutritional status and survival in patients with cancer.
McMillan DC
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):223-6. PubMed ID: 19318937
[TBL] [Abstract][Full Text] [Related]
5. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer.
McSorley ST; Black DH; Horgan PG; McMillan DC
Clin Nutr; 2018 Aug; 37(4):1279-1285. PubMed ID: 28566220
[TBL] [Abstract][Full Text] [Related]
6. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score.
Douglas E; McMillan DC
Cancer Treat Rev; 2014 Jul; 40(6):685-91. PubMed ID: 24321611
[TBL] [Abstract][Full Text] [Related]
7. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC
Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380
[TBL] [Abstract][Full Text] [Related]
8. Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer.
Kishiki T; Masaki T; Matsuoka H; Kobayashi T; Suzuki Y; Abe N; Mori T; Sugiyama M
Am J Surg; 2013 Aug; 206(2):234-40. PubMed ID: 23827511
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance.
Tuomisto AE; Mäkinen MJ; Väyrynen JP
World J Gastroenterol; 2019 Aug; 25(31):4383-4404. PubMed ID: 31496619
[TBL] [Abstract][Full Text] [Related]
10. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.
Roxburgh CS; McMillan DC
Future Oncol; 2010 Jan; 6(1):149-63. PubMed ID: 20021215
[TBL] [Abstract][Full Text] [Related]
11. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.
Dolan RD; Lim J; McSorley ST; Horgan PG; McMillan DC
Sci Rep; 2017 Dec; 7(1):16717. PubMed ID: 29196718
[TBL] [Abstract][Full Text] [Related]
12. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
13. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis.
Dolan RD; McSorley ST; Horgan PG; Laird B; McMillan DC
Crit Rev Oncol Hematol; 2017 Aug; 116():134-146. PubMed ID: 28693795
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
15. Worse Preoperative Status Based on Inflammation and Host Immunity Is a Risk Factor for Surgical Site Infections in Colorectal Cancer Surgery.
Sagawa M; Yoshimatsu K; Yokomizo H; Yano Y; Okayama S; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Kato H; Naritaka Y
J Nippon Med Sch; 2017; 84(5):224-230. PubMed ID: 29142183
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review.
Dolan RD; Laird BJA; Horgan PG; McMillan DC
Crit Rev Oncol Hematol; 2018 Dec; 132():130-137. PubMed ID: 30447918
[TBL] [Abstract][Full Text] [Related]
17. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.
McMillan DC
Cancer Treat Rev; 2013 Aug; 39(5):534-40. PubMed ID: 22995477
[TBL] [Abstract][Full Text] [Related]
18. The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers.
Watt DG; Proctor MJ; Park JH; Horgan PG; McMillan DC
PLoS One; 2015; 10(11):e0142159. PubMed ID: 26544968
[TBL] [Abstract][Full Text] [Related]
19. [The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].
Gorham J; Ameye L; Paesmans M; Berghmans T; Sculier JP; Meert AP
Rev Mal Respir; 2016 Nov; 33(9):759-765. PubMed ID: 27017064
[TBL] [Abstract][Full Text] [Related]
20. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Karhu T; Herzig KH; Minkkinen I; Mäkinen MJ; Karttunen TJ; Tuomisto A
Br J Cancer; 2019 Jan; 120(2):238-246. PubMed ID: 30563990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
